您的当前位置：首页 > 行业数据 > 和誉首个商业化创新药匹米替尼(ABSK021)将

和誉首个商业化创新药匹米替尼(ABSK021)将

行业数据

下载图片

原图定位

同报告图片

/ 4

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

所属报告：

和誉（2256.HK）-港股公司首次覆盖：中国小分子新药研发标兵迎接商业化转型元年-251002（44页）.pdf

打包全文图表

4.1 靶向药物治疗 TGCT 在中美市场的发展 ................................................................................................ 7 4.2 CSF-1R 靶向药物：匹米替尼的临床数据在安全性和疗效上皆占优 ...................................................... 8 5. FGFR 抑制剂：ABSK011 激烈竞争中后来居上，该 FGFR4 有望成为肝癌领域 FIC 产品 ........................... 11 5.1 安全性和耐药问题造成泛 FGFR 抑制剂市场空间存在瓶颈 ................................................................. 12 5.2 高选择性 FGFR 抑制剂的开发 ............................................................................................................ 15 5.3 FGFR4 选择性抑制剂：依帕戈替尼（ABSK011）是肝细胞癌全球首款进入关键临床阶段靶向药 ..... 17 5.4 FGFR2/3 选择性抑制剂：ABSK061 针对胃癌和软骨发育不全症两个适应症展开 .............................. 23 6. ABSK043：口服 PD-L1 小分子已进临床，等待与 EGFR 小分子联合治疗的注册性临床结果 ..................... 27 7. 未来：进军 Pan-RAS 抑制剂 ......................................................................................................................... 32 8. 估值 ................................................................................................................................................................ 37 财务预测表 .................................................................................................................................................................. 41 投资风险...................................................................................................................................................................... 42 投资评级定义 .............................................................................................................................................................. 43

行业数据原图定位